Sienna Biopharmaceuticals, Inc.
SNNAQ · OTC
12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $157 | $120 | $67 | $32 |
| Gross Profit | -$157 | -$120 | -$67 | -$32 |
| % Margin | – | – | – | – |
| R&D Expenses | $51,592 | $30,484 | $10,993 | $2,407 |
| G&A Expenses | $24,906 | $18,087 | $9,696 | $8,703 |
| SG&A Expenses | $24,906 | $18,087 | $9,696 | $8,703 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $95 | $0 |
| Operating Expenses | $76,498 | $48,571 | $20,689 | $11,110 |
| Operating Income | -$76,498 | -$48,571 | -$20,689 | -$11,110 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $3,027 | -$2,264 | -$473 | -$184 |
| Pre-Tax Income | -$73,471 | -$50,835 | -$21,162 | -$11,294 |
| Tax Expense | -$157 | -$290 | $663 | $0 |
| Net Income | -$73,314 | -$50,545 | -$21,825 | -$11,294 |
| % Margin | – | – | – | – |
| EPS | -3.59 | -5.19 | -11.23 | -5.81 |
| % Growth | 30.8% | 53.8% | -93.3% | – |
| EPS Diluted | -3.59 | -5.19 | -11.23 | -5.81 |
| Weighted Avg Shares Out | 20,450 | 9,735 | 1,944 | 1,944 |
| Weighted Avg Shares Out Dil | 20,450 | 9,735 | 1,944 | 1,944 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $568 | $547 |
| Depreciation & Amortization | $157 | $120 | $67 | $32 |
| EBITDA | -$76,341 | -$48,451 | -$20,622 | -$11,078 |
| % Margin | – | – | – | – |